Eagle Harbor Asset Management’s Pfizer PFE Stock Holding History

Eagle Harbor Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,642	Closed	-$253K	–	119
2023 Q3	$253K	Sell	7,642 -9,256	-55%	-$327K	0.33%	91
2023 Q2	$620K	Sell	16,898 -566	-3%	-$22K	0.81%	39
2023 Q1	$713K	Buy	17,464 +175	+1%	+$7.56K	0.97%	33
2022 Q4	$886K	Sell	17,289 -102	-0.6%	-$4.89K	1.3%	25
2022 Q3	$761K	Buy	17,391 +2,424	+16%	+$118K	1.31%	26
2022 Q2	$785K	Buy	14,967 +1,102	+8%	+$56.2K	1.21%	25
2022 Q1	$718K	Sell	13,865 -506	-4%	-$26.3K	0.93%	32
2021 Q4	$852K	Buy	+14,371	New	+$712K	1.12%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Eagle Harbor Asset Management's PFE Position: Q4 2023 in Review

Eagle Harbor Asset Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 7,642 shares — an estimated $253K sold.

Eagle Harbor Asset Management first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $886K in Q4 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Eagle Harbor Asset Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Eagle Harbor Asset Management sold 7,642 Pfizer shares in Q4 2023, an estimated $253K.
Eagle Harbor Asset Management first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
Eagle Harbor Asset Management's Pfizer position peaked at $886K in Q4 2022.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Eagle Harbor Asset Management's 13F filing for Q4 2023, filed 11 Aug 2026.